["{\n\"step_by_step_thinking\": \"None of the provided documents mention FTO (Forkhead box protein O) or pancreatic cancer development. The first document discusses a controlled trial on azapropazone in tinnitus, the second document reviews the pharmacodynamic and pharmacokinetic properties of cilazapril and its therapeutic potential in cardiovascular disease, the third document discusses laparoscopic cholecystectomy, and the fourth document describes an improved electronic gate technique for particle counting and sizing. There is no information about FTO or pancreatic cancer development in any of these documents.\",\n\"answer_choice\": B"]